Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 2
1947 2
1948 2
1949 5
1950 4
1952 2
1953 1
1954 1
1956 2
1957 2
1958 4
1959 2
1960 3
1961 3
1962 3
1964 2
1965 1
1967 6
1968 3
1969 6
1970 3
1971 3
1972 4
1973 3
1975 3
1976 10
1977 3
1978 2
1979 6
1980 7
1981 4
1982 4
1983 11
1984 12
1985 12
1986 17
1987 17
1988 36
1989 22
1990 30
1991 35
1992 32
1993 30
1994 30
1995 34
1996 13
1997 26
1998 25
1999 25
2000 22
2001 25
2002 32
2003 24
2004 21
2005 38
2006 34
2007 40
2008 38
2009 41
2010 49
2011 51
2012 57
2013 56
2014 35
2015 41
2016 57
2017 61
2018 42
2019 44
2020 49
2021 48
2022 46
2023 36
2024 23

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,399 results

Results by year

Filters applied: . Clear all
Page 1
A decade of clinical development of PARP inhibitors in perspective.
Mateo J, Lord CJ, Serra V, Tutt A, Balmaña J, Castroviejo-Bermejo M, Cruz C, Oaknin A, Kaye SB, de Bono JS. Mateo J, et al. Among authors: kaye sb. Ann Oncol. 2019 Sep 1;30(9):1437-1447. doi: 10.1093/annonc/mdz192. Ann Oncol. 2019. PMID: 31218365 Free PMC article. Review.
Herpes simplex keratitis.
Kaye SB, Baker K. Kaye SB, et al. J Med Microbiol. 1996 Jul;45(1):3-5. doi: 10.1099/00222615-45-1-3. J Med Microbiol. 1996. PMID: 8667408 No abstract available.
Reply.
Steger B, Romano V, Kaye SB. Steger B, et al. Among authors: kaye sb. Cornea. 2016 Mar;35(3):e8. doi: 10.1097/ICO.0000000000000749. Cornea. 2016. PMID: 26840597 No abstract available.
PARP inhibitors: the race is on.
Brown JS, Kaye SB, Yap TA. Brown JS, et al. Among authors: kaye sb. Br J Cancer. 2016 Mar 29;114(7):713-5. doi: 10.1038/bjc.2016.67. Br J Cancer. 2016. PMID: 27022824 Free PMC article. No abstract available.
Gene-based antiangiogenic applications for corneal neovascularization.
Liu S, Romano V, Steger B, Kaye SB, Hamill KJ, Willoughby CE. Liu S, et al. Among authors: kaye sb. Surv Ophthalmol. 2018 Mar-Apr;63(2):193-213. doi: 10.1016/j.survophthal.2017.10.006. Epub 2017 Nov 15. Surv Ophthalmol. 2018. PMID: 29080632 Review.
Update on tubulin-binding agents.
Attard G, Greystoke A, Kaye S, De Bono J. Attard G, et al. Among authors: kaye s. Pathol Biol (Paris). 2006 Mar;54(2):72-84. doi: 10.1016/j.patbio.2005.03.003. Pathol Biol (Paris). 2006. PMID: 16545633 Review.
Amoebicidal Activity of Poly-Epsilon-Lysine Functionalized Hydrogels.
Kennedy SM, Deshpande P, Gallagher AG, Horsburgh MJ, Allison HE, Kaye SB, Wellings DA, Williams RL. Kennedy SM, et al. Among authors: kaye sb. Invest Ophthalmol Vis Sci. 2022 Jan 3;63(1):11. doi: 10.1167/iovs.63.1.11. Invest Ophthalmol Vis Sci. 2022. PMID: 34994769 Free PMC article.
1,399 results